- Home
- FRSX vs GOVX Comparison
FRSX vs GOVX Comparison
Compare FRSX & GOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRSX
- GOVX
- Stock Information
- Founded
- FRSX N/A
- GOVX 2001
- Country
- FRSX Israel
- GOVX United States
- Employees
- FRSX N/A
- GOVX N/A
- Industry
- FRSX Computer Software: Prepackaged Software
- GOVX Biotechnology: Pharmaceutical Preparations
- Sector
- FRSX Technology
- GOVX Health Care
- Exchange
- FRSX Nasdaq
- GOVX Nasdaq
- Market Cap
- FRSX 7.0M
- GOVX 7.6M
- IPO Year
- FRSX 2017
- GOVX N/A
- Fundamental
- Price
- FRSX $0.36
- GOVX $0.77
- Analyst Decision
- FRSX
- GOVX Strong Buy
- Analyst Count
- FRSX 0
- GOVX 4
- Target Price
- FRSX N/A
- GOVX $10.50
- AVG Volume (30 Days)
- FRSX 411.5K
- GOVX 975.8K
- Earning Date
- FRSX 08-15-2025
- GOVX 07-28-2025
- Dividend Yield
- FRSX N/A
- GOVX N/A
- EPS Growth
- FRSX N/A
- GOVX N/A
- EPS
- FRSX N/A
- GOVX N/A
- Revenue
- FRSX $452,000.00
- GOVX $6,143,044.00
- Revenue This Year
- FRSX N/A
- GOVX N/A
- Revenue Next Year
- FRSX N/A
- GOVX N/A
- P/E Ratio
- FRSX N/A
- GOVX N/A
- Revenue Growth
- FRSX N/A
- GOVX 1943.07
- 52 Week Low
- FRSX $0.31
- GOVX $0.43
- 52 Week High
- FRSX $2.63
- GOVX $9.56
- Technical
- Relative Strength Index (RSI)
- FRSX 42.21
- GOVX 52.63
- Support Level
- FRSX $0.35
- GOVX $0.69
- Resistance Level
- FRSX $0.40
- GOVX $0.80
- Average True Range (ATR)
- FRSX 0.03
- GOVX 0.05
- MACD
- FRSX 0.00
- GOVX 0.01
- Stochastic Oscillator
- FRSX 58.14
- GOVX 77.18
About FRSX Foresight Autonomous Holdings Ltd.
Foresight Autonomous Holdings Ltd is a technology company engaged in the design, development and commercialization of vision systems for the automotive industry. The company develops both in-line-of-sight vision systems and beyond-line-of-sight cellular-based applications through its wholly-owned subsidiaries. Its systems are designed to improve driving safety by enabling accurate and reliable threat detection while ensuring the lowest rates of false alerts. Foresight is pursuing several markets and believes its modern systems will revolutionize automotive safety by providing an automotive-grade, cost-effective platform.
About GOVX GeoVax Labs Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.